Clinical Trial Update: Safety and Efficacy of Azzalure/Dysport, Restylane/Emervel Filler and Restylane Skinbooster Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating safety and efficacy of Azzalure/Dysport, Restylane/Emervel filler, and Restylane Skinbooster for aesthetic indications; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aesthetic Conditions

Drugs mentioned

• Azzalure
• Dysport (abobotulinumtoxinA)
• Emervel (not provided)
• Restylane (hyaluronic acid dermal filler)
• Restylane Skinbooster (hyaluronic acid filler for skin boosting)

Snippet

Sponsor: Galderma R&D | Conditions: Aesthetics | Phase 4 | Status: COMPLETED | Results posted: 2019-09-30